Free Trial

BridgeBio Pharma (BBIO) Insider Trading & Ownership

BridgeBio Pharma logo
$68.78 -0.21 (-0.30%)
Closing price 05/5/2026 04:00 PM Eastern
Extended Trading
$69.00 +0.22 (+0.32%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BridgeBio Pharma (NASDAQ:BBIO) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
14.23%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
12
Amount Of
Insider Selling
(Last 12 Months)
$454.46M
Get BBIO Insider Trade Alerts

Want to know when executives and insiders are buying or selling BridgeBio Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BBIO Insider Buying and Selling by Quarter

BridgeBio Pharma Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/30/2026Sell2,000$71.58$143,160.00  
4/9/2026Sell40,000$74.62$2,984,800.00  
3/19/2026Buy$70.17$1,001 - $15,000
3/18/2026Buy$70.12$1,001 - $15,000
3/12/2026Sell40,000$68.73$2,749,200.00  
3/4/2026
Andrea Ellis
Andrea Ellis
Director
Sell64,921$64.87$4,211,425.27  
3/3/2026Buy$64.53$1,001 - $15,000
2/19/2026Sell28,053$71.39$2,002,703.67  
2/17/2026Sell510$74.31$37,898.10  
2/17/2026Sell10,000$75.46$754,600.00  
2/17/2026Sell13,600$74.72$1,016,192.00  
2/10/2026Sell40,000$71.94$2,877,600.00  
1/8/2026Sell40,000$73.97$2,958,800.00  
12/15/2025Sell30,011$74.64$2,240,021.04  
12/8/2025Sell2,000$74.26$148,520.00  
12/4/2025Sell40,000$74.40$2,976,000.00  
11/20/2025Sell26,156$65.84$1,722,111.04  
11/18/2025
Andrew Lo
Director
Sell55,000$65.69$3,612,950.00  
11/17/2025
Andrew Lo
Director
Sell40,599$66.67$2,706,735.33  
11/17/2025Sell10,000$66.65$666,500.00  
11/17/2025Sell16,934$66.46$1,125,433.64  
11/12/2025Sell25,484$66.07$1,683,727.88  
11/6/2025Sell40,000$63.15$2,526,000.00  
11/6/2025Sell61,031$63.72$3,888,895.32  
10/29/2025Sell198,359$66.58$13,206,742.22  
10/27/2025Sell1,641$65.00$106,665.00  
10/8/2025Sell40,000$54.78$2,191,200.00  
9/22/2025Buy$51.54$1,001 - $15,000
9/5/2025Sell74,000$53.16$3,933,840.00  
9/4/2025Sell40,000$51.34$2,053,600.00  
8/21/2025Sell42,237$49.48$2,089,886.76  
8/20/2025Sell26,156$48.82$1,276,935.92  
8/18/2025Sell17,353$50.23$871,641.19  
8/11/2025
Charles J Homcy
Director
Sell50,000$48.00$2,400,000.00  
8/8/2025
Charles J Homcy
Director
Sell250,000$46.05$11,512,500.00  
8/8/2025Buy$46.58$1,001 - $15,000
8/7/2025Sell1,000$45.44$45,440.00  
8/7/2025Sell40,000$45.45$1,818,000.00  
8/5/2025
Andrea Ellis
Andrea Ellis
Director
Sell17,167$49.00$841,183.00  
7/1/2025Sell40,000$42.54$1,701,600.00  
6/27/2025
Global Investors Lp Viking
Major Shareholder
Sell3,500,000$44.00$154,000,000.00  
6/26/2025Sell2,418$44.05$106,512.90  
6/26/2025Sell2,289$44.05$100,830.45  
6/24/2025Sell100,000$44.23$4,423,000.00  
6/10/2025Sell4,292$40.00$171,680.00  
5/20/2025Sell75,000$33.40$2,505,000.00  
5/19/2025Sell26,156$33.33$871,779.48  
5/12/2025
Genetic Disorder L.P. Kkr
Major Shareholder
Sell6,000,000$34.20$205,200,000.00  
(Data available from 1/1/2013 forward)

BBIO Insider Trading Activity - Frequently Asked Questions

The list of insiders at BridgeBio Pharma includes Andrea Ellis, Andrew Lo, Brian C Stephenson, Charles J Homcy, Frank Mccormick, Genetic Disorder L.P. Kkr, Global Investors Lp Viking, Hannah Valantine, Maricel Apuli, Neil Kumar, Randal W Scott, Ronald J Daniels, and Thomas Trimarchi. Learn more on insiders at BBIO.

14.23% of BridgeBio Pharma stock is owned by insiders. Learn more on BBIO's insider holdings.

The following insiders have sold BBIO shares in the last 24 months: Andrea Ellis ($6,424,108.27), Andrew Lo ($10,169,685.33), Brian C Stephenson ($3,095,549.59), Charles J Homcy ($13,912,500.00), Frank Mccormick ($21,670,247.22), Genetic Disorder L.P. Kkr ($552,310,000.00), Global Investors Lp Viking ($260,989,998.40), Hannah Valantine ($2,062,751.23), Maricel Apuli ($414,529.36), Neil Kumar ($57,590,949.35), Randal W Scott ($1,449,940.00), Ronald J Daniels ($3,888,895.32), and Thomas Trimarchi ($5,103,153.59).

Insiders have sold a total of 26,909,221 BridgeBio Pharma shares in the last 24 months for a total of $939,082,307.66 sold.

Gilbert Ray Cisneros, Jr. (D-CA) has bought shares of BridgeBio Pharma in the last year totaling $40,000.



This page (NASDAQ:BBIO) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners